Biomaterials offer cancer research the third dimension.

PubWeight™: 1.45‹?› | Rank: Top 5%

🔗 View Article (PMID 20094076)

Published in Nat Mater on February 01, 2010

Authors

Dietmar W Hutmacher1

Author Affiliations

1: Institute of Health and Biomedical Innovation, Queensland University of Technology, 60 Musk Avenue, Kelvin Grove Queensland 4059, Australia. dietmar.hutmacher@qut.edu.au

Articles citing this

Macroporous nanowire nanoelectronic scaffolds for synthetic tissues. Nat Mater (2012) 2.57

Assembly of complex cell microenvironments using geometrically docked hydrogel shapes. Proc Natl Acad Sci U S A (2013) 1.70

Three-dimensional magnetic assembly of microscale hydrogels. Adv Mater (2011) 1.13

Organ-on-a-chip platforms for studying drug delivery systems. J Control Release (2014) 1.06

Three-dimensional in vitro tumor models for cancer research and drug evaluation. Biotechnol Adv (2014) 1.03

Microengineering methods for cell-based microarrays and high-throughput drug-screening applications. Biofabrication (2011) 0.97

Recreating the tumor microenvironment in a bilayer, hyaluronic acid hydrogel construct for the growth of prostate cancer spheroids. Biomaterials (2012) 0.96

Nanoelectronics-biology frontier: From nanoscopic probes for action potential recording in live cells to three-dimensional cyborg tissues. Nano Today (2013) 0.96

Macromolecular crowding directs extracellular matrix organization and mesenchymal stem cell behavior. PLoS One (2012) 0.95

Porous chitosan-hyaluronic acid scaffolds as a mimic of glioblastoma microenvironment ECM. Biomaterials (2013) 0.93

Interactions between human osteoblasts and prostate cancer cells in a novel 3D in vitro model. Organogenesis (2011) 0.93

Synthetic nanoelectronic probes for biological cells and tissues. Annu Rev Anal Chem (Palo Alto Calif) (2013) 0.92

Cell-penetrating peptides: achievements and challenges in application for cancer treatment. J Biomed Mater Res A (2013) 0.90

Embedded multicellular spheroids as a biomimetic 3D cancer model for evaluating drug and drug-device combinations. Biomaterials (2013) 0.90

Osteomimicry of mammary adenocarcinoma cells in vitro; increased expression of bone matrix proteins and proliferation within a 3D collagen environment. PLoS One (2012) 0.90

Serum Proteins Enhance Dispersion Stability and Influence the Cytotoxicity and Dosimetry of ZnO Nanoparticles in Suspension and Adherent Cancer Cell Models. Nanoscale Res Lett (2015) 0.87

Generation of Multicellular Tumor Spheroids with Microwell-Based Agarose Scaffolds for Drug Testing. PLoS One (2015) 0.84

Determination of pore size distribution at the cell-hydrogel interface. J Nanobiotechnology (2011) 0.83

3D Porous Chitosan-Alginate Scaffolds as an In Vitro Model for Evaluating Nanoparticle-Mediated Tumor Targeting and Gene Delivery to Prostate Cancer. Biomacromolecules (2015) 0.81

Neuronal electrophysiological function and control of neurite outgrowth on electrospun polymer nanofibers are cell type dependent. Tissue Eng Part A (2013) 0.80

A tissue-engineered subcutaneous pancreatic cancer model for antitumor drug evaluation. Int J Nanomedicine (2013) 0.80

Hydrogel Pore-Size Modulation for Enhanced Single-Cell Western Blotting. Adv Mater (2015) 0.79

Engineering strategies to mimic the glioblastoma microenvironment. Adv Drug Deliv Rev (2014) 0.78

Methods for culturing human femur tissue explants to study breast cancer cell colonization of the metastatic niche. J Vis Exp (2015) 0.78

Prostate cancer xenografts engineered from 3D precision-porous poly(2-hydroxyethyl methacrylate) hydrogels as models for tumorigenesis and dormancy escape. Biomaterials (2014) 0.78

Microfabricated polymeric vessel mimetics for 3-D cancer cell culture. Biomaterials (2013) 0.78

3D bioprinting: improving in vitro models of metastasis with heterogeneous tumor microenvironments. Dis Model Mech (2017) 0.78

Recapitulating tumour microenvironment in chitosan-gelatin three-dimensional scaffolds: an improved in vitro tumour model. J R Soc Interface (2012) 0.77

Design standards for engineered tissues. Biotechnol Adv (2012) 0.77

Tumor Growth Suppression Induced by Biomimetic Silk Fibroin Hydrogels. Sci Rep (2016) 0.77

Capillary force seeding of sphere-templated hydrogels for tissue-engineered prostate cancer xenografts. Tissue Eng Part C Methods (2013) 0.77

Modeling the tumor microenvironment using chitosan-alginate scaffolds to control the stem-like state of glioblastoma cells. Biomater Sci (2015) 0.76

Effects of poly(L-lactide-ε-caprolactone) and magnesium hydroxide additives on physico-mechanical properties and degradation of poly(L-lactic acid). Biomater Res (2016) 0.75

Interactions among Lung Cancer Cells, Fibroblasts, and Macrophages in 3D Co-Cultures and the Impact on MMP-1 and VEGF Expression. PLoS One (2016) 0.75

An Optically Controlled 3D Cell Culturing System. Adv Optoelectron (2011) 0.75

Effect of vascular formed endothelial cell network on the invasive capacity of melanoma using the in vitro 3D co-culture patterning model. PLoS One (2014) 0.75

Digital microfluidic three-dimensional cell culture and chemical screening platform using alginate hydrogels. Biomicrofluidics (2015) 0.75

Bioengineering Models for Breast Cancer Research. Breast Cancer (Auckl) (2016) 0.75

Tailoring hydrogel surface properties to modulate cellular response to shear loading. Acta Biomater (2016) 0.75

Development of a Biomimetic Chondroitin Sulfate-modified Hydrogel to Enhance the Metastasis of Tumor Cells. Sci Rep (2016) 0.75

Human Organotypic Lung Tumor Models: Suitable For Preclinical 18F-FDG PET-Imaging. PLoS One (2016) 0.75

3D polylactide-based scaffolds for studying human hepatocarcinoma processes in vitro. Sci Technol Adv Mater (2012) 0.75

Biofabricated constructs as tissue models: a short review. J Mater Sci Mater Med (2015) 0.75

Articles cited by this

Putting tumours in context. Nat Rev Cancer (2001) 12.37

Modeling tissue morphogenesis and cancer in 3D. Cell (2007) 7.49

Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods (2007) 7.43

Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol (2005) 5.12

Cell culture: biology's new dimension. Nature (2003) 4.51

Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited. J Cell Biol (2009) 4.04

Engineering tumors with 3D scaffolds. Nat Methods (2007) 3.96

The use of 3-D cultures for high-throughput screening: the multicellular spheroid model. J Biomol Screen (2004) 2.94

Can cancer be reversed by engineering the tumor microenvironment? Semin Cancer Biol (2008) 2.07

Taking the study of cancer cell survival to a new dimension. Cell (2002) 2.03

Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model. Cancer Res (2007) 1.46

Simplifying the extracellular matrix for 3-D cell culture and tissue engineering: a pragmatic approach. J Cell Biochem (2007) 1.32

Translating tissue engineering technology platforms into cancer research. J Cell Mol Med (2009) 1.29

Peptide amphiphile nanostructure-heparin interactions and their relationship to bioactivity. Biomaterials (2008) 1.24

New dimensions in tumor immunology: what does 3D culture reveal? Trends Mol Med (2008) 1.22

Biomaterials: Spotlight on hydrogels. Nat Mater (2009) 1.16

Designer self-assembling Peptide nanofiber scaffolds for study of 3-d cell biology and beyond. Adv Cancer Res (2008) 1.15